Study Summary
This trial is testing a new way to dissolve clots in people with DVT. They will compare it to the current standard of care and also look at the financial implications.
Eligible Conditions
- Deep Vein Thrombosis (DVT)
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 1 month
1 month
Post-thrombotic Syndrome (PTS) severity using the Villalta score
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
30 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 month
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
401 Previous Clinical Trials
158,339 Total Patients Enrolled
Penumbra Inc.Industry Sponsor
33 Previous Clinical Trials
8,535 Total Patients Enrolled
Aaron Rohr, MDPrincipal InvestigatorInterventional Radiology-Vascular
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You have the ability to undergo thrombolysis in combination with Indigo endhole aspiration device.
You are at least 18 years old.
Onset of acute DVT occurred <14 days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments